Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Djulbegovic

Showing results (41-50 of 315) with videos related to

Pageof 32
Sort By:
BMC Medical Research Methodology|February 18, 2011
The Australian 'FORM' approach to guideline development: the quest for the perfect systemPhilipp Dahm, Benjamin Djulbegovic
Cancer Treatment Reviews|November 9, 2004
High-quality evidence in oncology from 20th April to 11th May 2004: a summaryBenjamin Djulbegovic, Sam Vincent
Cancer Treatment Reviews|November 16, 2004
High-quality evidence in oncology from 18th May to 15th June 2004: a summaryBenjamin Djulbegovic, Sam Vincent
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 16, 2008
When is diagnostic testing inappropriate or irrational? Acceptable regret approachIztok Hozo, Benjamin Djulbegovic
Clinical Evidence|September 16, 2006
Myeloma (multiple)Ambuj Kumar, Benjamin Djulbegovic
Cancer Treatment Reviews|April 26, 2005
High-quality evidence in oncology from 1st September to 14th October 2004: a summaryBenjamin Djulbegovic, Liz Bickerdike
Journal of the Royal Society of Medicine|January 30, 2013
Comparator bias: why comparisons must address genuine uncertaintiesHoward Mann, Benjamin Djulbegovic
JAMA|October 17, 2018
Bisphosphonates for Patients Diagnosed With Multiple MyelomaRahul Mhaskar, Benjamin Djulbegovic
Cancer Treatment and Research|October 3, 2023
Which Threshold Model?Benjamin Djulbegovic, Iztok Hozo
JAMA Oncology|July 9, 2016
Iron Supplementation for Chemotherapy-Induced Anemia in Patients Receiving Erythropoiesis-Stimulating AgentsRahul Mhaskar, Benjamin Djulbegovic
Pageof 32

Showing results (41-50 of 315) with videos related to

Sort By:
Pageof 32
BMC Medical Research Methodology|February 18, 2011
The Australian 'FORM' approach to guideline development: the quest for the perfect systemPhilipp Dahm, Benjamin Djulbegovic
Cancer Treatment Reviews|November 9, 2004
High-quality evidence in oncology from 20th April to 11th May 2004: a summaryBenjamin Djulbegovic, Sam Vincent
Cancer Treatment Reviews|November 16, 2004
High-quality evidence in oncology from 18th May to 15th June 2004: a summaryBenjamin Djulbegovic, Sam Vincent
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 16, 2008
When is diagnostic testing inappropriate or irrational? Acceptable regret approachIztok Hozo, Benjamin Djulbegovic
Clinical Evidence|September 16, 2006
Myeloma (multiple)Ambuj Kumar, Benjamin Djulbegovic
Cancer Treatment Reviews|April 26, 2005
High-quality evidence in oncology from 1st September to 14th October 2004: a summaryBenjamin Djulbegovic, Liz Bickerdike
Journal of the Royal Society of Medicine|January 30, 2013
Comparator bias: why comparisons must address genuine uncertaintiesHoward Mann, Benjamin Djulbegovic
JAMA|October 17, 2018
Bisphosphonates for Patients Diagnosed With Multiple MyelomaRahul Mhaskar, Benjamin Djulbegovic
Cancer Treatment and Research|October 3, 2023
Which Threshold Model?Benjamin Djulbegovic, Iztok Hozo
JAMA Oncology|July 9, 2016
Iron Supplementation for Chemotherapy-Induced Anemia in Patients Receiving Erythropoiesis-Stimulating AgentsRahul Mhaskar, Benjamin Djulbegovic
Pageof 32